Evidence map›Paper›PMID 37242444›Full record

ArticlePharmaceuticals (Basel, Switzerland)2023

In Vitro and In Vivo Effects of Ulvan Polysaccharides from

Jorge García-Márquez, Bruna Rodrigues Moreira, Piedad Valverde-Guillén, Sofía Latorre-Redoli, Candela T Caneda-Santiago, Gabriel Acién, Eduardo Martínez-Manzanares, Manuel Marí-Beffa, Roberto T Abdala-Díaz

Open access · goldAbstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
9.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Marine drugs · 2025
    Review
  11. Special Issue "Novel Anti-Proliferative Agents".Pharmaceuticals (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Jorge García-MárquezDepartment of Microbiology, Faculty of Science, Andalusian Institute of Blue Biotechnology and Development (IBYDA), Malaga University, Campus Universitario de Teatinos s/n, 29071 Malaga, Spain.ORCID 0000-0001-8175-0409
Bruna Rodrigues MoreiraPhycology Laboratory, Department of Botany, Biological Sciences Center, Federal University of Santa Catarina, Florianópolis 88040-900, SC, Brazil.ORCID 0000-0002-7766-138X
Piedad Valverde-GuillénDepartment of Cell Biology, Genetics and Physiology, Faculty of Science, Andalusian Institute of Blue Biotechnology and Development (IBYDA), Malaga University, Campus Universitario de Teatinos s/n, 29071 Malaga, Spain.ORCID 0000-0002-6743-3076
Sofía Latorre-RedoliDepartment of Cell Biology, Genetics and Physiology, Faculty of Science, Andalusian Institute of Blue Biotechnology and Development (IBYDA), Malaga University, Campus Universitario de Teatinos s/n, 29071 Malaga, Spain.ORCID 0000-0002-4244-2072
Candela T Caneda-SantiagoDepartment of Cell Biology, Genetics and Physiology, Faculty of Science, Andalusian Institute of Blue Biotechnology and Development (IBYDA), Malaga University, Campus Universitario de Teatinos s/n, 29071 Malaga, Spain.
Gabriel AciénDepartment of Chemical Engineering, Almería University, 04120 Almería, Spain.ORCID 0000-0002-8434-0365
Eduardo Martínez-ManzanaresDepartment of Microbiology, Faculty of Science, Andalusian Institute of Blue Biotechnology and Development (IBYDA), Malaga University, Campus Universitario de Teatinos s/n, 29071 Malaga, Spain.ORCID 0000-0002-4227-0960
Manuel Marí-BeffaDepartment of Cell Biology, Genetics and Physiology, Faculty of Science, Andalusian Institute of Blue Biotechnology and Development (IBYDA), Malaga University, Campus Universitario de Teatinos s/n, 29071 Malaga, Spain.
Roberto T Abdala-DíazDepartment of Ecology and Geology, Faculty of Science, Andalusian Institute of Blue Biotechnology and Development (IBYDA), Malaga University, Campus Universitario de Teatinos s/n, 29071 Malaga, Spain.
Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine · ESInstituto de Investigación Biomédica de Málaga · ESUniversidade Federal de Santa Catarina · BRUniversity of Almería · ES

Funding

Coordination for the Improvement of Higher Education Personnel (Brazil) CAPES 88882.438333/2019-01 (to B.R.M.)Coordination for the Improvement of Higher Education Personnel (Brazil) CAPES/PRINT process nos. 88887.578926/2020-00 (to B.R.M.)Regional Government of Andalusia UMA18-FEDERJA-274University of Malaga A.1. grants (to C.C.-S.)University of Malaga A.1. grants (to P.V.-G.)University of Malaga A.1. grants (to S.L.-R.)
6 · The paper itself

Abstract

One of the main bioactive compounds of interest from the

Indexed as

cytotoxic activityhuman cancer cell linespolysaccharidesulvanUlva rigidazebrafish embryo toxicity test

Identifiers

PMID37242444
PMCPMC10222840
OpenAlexW4367319842

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.